Vitamin D affects bone strength, immune balance, and brain performance, so vitamin D status deserves a data-driven plan.
When vitamin D runs low, people often notice the “soft signs” first. Lower energy. Slower recovery. More aches. Lower mood. Poorer sleep quality. More brain fog.
If brain fog sounds familiar, start with this quick list of common symptoms: https://mindbodyneurology.com/symptoms-of-brain-fog/If sleep feels fragile, this connects the dots: https://mindbodyneurology.com/poor-sleep-causes-brain-fog/If stress feels like the driver, read this next: https://mindbodyneurology.com/stress-cortisol-brain-fog/
WHY VITAMIN D MATTERS OUTSIDE OF BONES
Vitamin D helps your gut absorb calcium and helps keep calcium and phosphate in a healthy range. That is the classic role. Yet the larger story involves signaling. Vitamin D receptors show up across many tissues. Vitamin D influences inflammation balance, immune function, neuromuscular function, and aspects of metabolism. When that signaling stays steady, the body tends to run more predictably.
This matters for day-to-day function, not only long-term prevention. Your immune system needs stable inputs. Your muscles need stable inputs. Your brain functions best when the body stays stable.
Bone health and osteoporosis
Vitamin D supports calcium absorption and bone mineralization. Trials show vitamin D plus calcium can raise bone mineral density in some postmenopausal women and older men. Results look inconsistent for falls and fracture reduction, and studies on muscle strength and muscle decline show mixed findings.
Cancer
Vitamin D influences pathways tied to cell growth and immune regulation. Even so, most research does not show a clear link between blood 25(OH)D levels and overall cancer risk. Clinical trials also fail to show consistent cancer prevention from vitamin D supplements, with or without calcium. Some data suggests adequate 25(OH)D levels might link with lower cancer mortality, but researchers still need stronger trial data.
Cardiovascular disease
Low vitamin D status links with vascular dysfunction, arterial stiffening, left ventricular hypertrophy, and lipid abnormalities. Observational studies often show lower cardiovascular risk in people with higher 25(OH)D levels, but randomized trials do not confirm that vitamin D supplements reduce cardiovascular events.
Depression
Researchers associate low 25(OH)D with higher depression risk in observational studies. Clinical trials have not shown consistent prevention of depression or reliable symptom improvement from vitamin D supplements.
Type 2 diabetes
Observational studies often show an inverse relationship between vitamin D status and blood glucose markers. Clinical trials do not show consistent improvement in glucose control or progression from prediabetes to type 2 diabetes with vitamin D supplementation, especially when baseline vitamin D status is sufficient.
Weight loss
Higher body weight often correlates with lower vitamin D status. Current research does not support vitamin D supplements as a weight-loss strategy.
VITAMIN D AND THE BRAIN
Brain health depends on three foundations: stable energy production, stable sleep timing, and stable immune tone. Vitamin D intersects with all three.
Multiple sclerosis (MS)
Lower 25(OH)D levels show up repeatedly in MS research. Studies link higher vitamin D status with lower MS risk and lower disease activity in established MS, yet trial results stay mixed.
Dementia and Alzheimer’s disease
Meta-analyses and large cohort work link lower 25(OH)D with higher risk of dementia and Alzheimer’s disease. This does not prove supplementation prevents dementia, but the association is consistent across many datasets.
Parkinson’s disease
Systematic reviews and meta-analyses report lower 25(OH)D in Parkinson’s and link low vitamin D with higher risk of Parkinson’s or worse symptom severity. Trials that test vitamin D as a treatment still leave open questions.
Stroke and cerebrovascular disease
Population studies and meta-analyses link lower 25(OH)D with higher stroke risk. Supplement trials often fail to show clear stroke prevention, which suggests vitamin D status might track overall risk rather than drive it alone.
Schizophrenia and psychotic disorders
Reviews report a high prevalence of vitamin D deficiency in schizophrenia and link low 25(OH)D with schizophrenia risk. Causality remains debated, but the association appears in multiple lines of evidence, including birth cohort data..
Migraine and severe headache syndromes
Several studies report lower 25(OH)D in migraine populations, and newer population analyses show an inverse relationship between vitamin D levels and migraine prevalence. Results still vary across studies, so I treat this as a supportive factor, not a primary cause.
Epilepsy and seizure disorders
Vitamin D deficiency is common in epilepsy, in part due to antiseizure medications and reduced outdoor activity. Some studies link lower 25(OH)D with worse seizure control or cognitive outcomes, but evidence still varies by age group and epilepsy subtype
People often try to solve brain fog with one lever. Coffee. A new supplement stack. A strict diet. A better planner. Those steps miss the big pattern. Brain fog often reflects a systems problem. Sleep disruption, stress physiology, nutrient gaps, and inflammation often cluster together.
If you want a broad, practical list of nutrient drivers that show up on labs, read this: https://mindbodyneurology.com/nutrient-deficiencies-that-cause-brain-fog/ If hormones feel involved, this page helps: https://mindbodyneurology.com/hormone-imbalance-brain-fog/ If stress hits memory and focus, start here: https://mindbodyneurology.com/cortisol-and-memory-how-stress-disrupts-focus/
THE TWO VITAMIN D LAB MARKERS MOST PEOPLE MIX UP
Most people think “vitamin D” equals one number. Two different lab markers show up in medical charts. They do not mean the same thing.
25-HYDROXY VITAMIN D (25(OH)D): THE STORAGE AND SUPPLY MARKER
Most “vitamin D” conversations revolve around one number, 25-hydroxyvitamin D, written as 25(OH)D. This lab reflects supply. Your liver converts vitamin D into 25(OH)D, and this number tracks your vitamin D reserves over time.
If you want a data-driven plan, track 25(OH)D. This number tells you if your body has enough vitamin D on board.
1,25-DIHYDROXY VITAMIN D (1,25(OH)2D): THE ACTIVE HORMONE
The second marker, 1,25-dihydroxyvitamin D, written as 1,25(OH)2D, functions as the active hormone signal. Your kidneys produce much of it under tight control from parathyroid hormone, calcium, phosphate, and related regulators.
WHY I TRACK BOTH IN CLINICAL WORK
In many people, 25(OH)D gives the clearest picture of vitamin D status. Yet I also measure 1,25(OH)2D because the relationship between the two markers sometimes breaks the “textbook” pattern. I see patients where 25(OH)D runs low while 1,25(OH)2D runs high, and I also see cases where both run low.
A wide gap between low 25(OH)D and high 1,25(OH)2D often points toward increased conversion into the active form. Two common drivers show up in the medical literature. One involves parathyroid hormone driven conversion in the kidney.
The other involves immune driven conversion outside the kidney in granulomatous inflammation, where macrophages produce extra 1,25(OH)2D.
This matters because vitamin D decisions should not rely on a single number in every patient. The full picture includes symptoms plus calcium status, kidney function, and context.
A NOTE ON HIGH 1,25(OH)2D AND SUPPLEMENT TOLERANCE
Some inflammatory conditions, especially granulomatous disease, link with substrate dependent production of 1,25(OH)2D outside the kidney. In that setting, adding large amounts of vitamin D substrate sometimes links with hypercalcemia or hypercalciuria in susceptible patients.
This does not mean vitamin D supplements pose a problem for everyone. It means the lab pattern guides the plan. When I see a large split, I treat dosing with more care and track calcium handling rather than pushing higher and higher intake.
WHY VITAMIN D DROPS SO OFTEN
Indoor life blocks UVB exposure. UVB drives vitamin D production in skin. Standard window glass blocks UVB, so bright sunlight through a window does not build vitamin D. A sunny room feels nice, yet your skin does not get the UVB signal it needs.
Winter makes this worse in northern states. The sun angle shifts. Outdoor UVB intensity drops. Many people spend less time outside. Add work schedules, school schedules, and cold weather habits, and vitamin D drops become predictable.
Other factors also matter. Older adults synthesize less vitamin D in skin. Darker skin needs more UV exposure to generate the same vitamin D response. Higher body fat often correlates with lower circulating 25(OH)D because vitamin D partitions into adipose tissue.
FOOD HELPS, YET LIGHT DRIVES THE BIGGEST SWING
Food sources help. Fatty fish helps. Fortified foods help. Some people use oral vitamin D. Still, many people in northern climates end winter with low 25(OH)D. A nutrition plan matters, yet sunlight or UVB exposure often drives the biggest shift.
Some people also prefer a non-pill approach. Others react poorly to supplements. Others want a plan that mimics normal physiology. Those people often do well with a controlled UVB strategy.
HOW A UVB VITAMIN D LAMP FITS A SMART PLAN
UVB based vitamin D production has built-in brakes. With ongoing UVB exposure, excess previtamin D3 and vitamin D3 shift into inactive photoproducts such as lumisterol and tachysterol.
This photodegradation limits endless vitamin D production from light exposure, and it explains why vitamin D intoxication does not occur from sunlight exposure alone.
After skin production, your body still regulates conversion into 1,25(OH)2D through kidney control systems tied to calcium and phosphate balance. So in most people, UVB exposure raises 25(OH)D gradually while active hormone production stays under physiologic control.
This is also why I like a timed UVB lamp approach for the right patient. It supports upstream production and respects the body’s regulation, especially when the plan includes lab follow-up.
IMPORTANT CLINICAL NOTE
Granulomatous disease and select malignancy settings sit outside “typical” regulation because immune cells can produce extra 1,25(OH)2D. In those patients, any strategy, supplements or UVB, needs closer monitoring of calcium handling and symptoms.
THE SPERTI VITAMIN D SUNLAMP: WHAT TO KNOW
The Sperti Vitamin D Sunlamp (light box) focuses on UVB exposure for vitamin D production. The product listing highlights a short, controlled session design.
It includes an adjustable timer for 1 to 5 minutes with automatic shutoff. It includes UV-blocking eyewear. It uses UVB bulbs designed for this purpose.
This matters because people often overdo light exposure when they try to “catch up.” Short sessions and a timer reduce that risk.
SAFETY FIRST WITH UVB LIGHT
UV light carries real risk. Respect it.
Follow the manufacturer instructions. Use the protective eyewear. Keep the recommended distance. Start with short sessions. Stop if skin redness occurs. Resume only after redness fully resolves.
Avoid UVB devices if you have a personal history of skin cancer or a strong family history of skin cancer. Avoid if you have extreme sun sensitivity. Review your medication list for photosensitivity risks. Some medications increase UV sensitivity.
If you feel unsure, talk with your clinician before starting. A measured plan beats guesswork.
A PRACTICAL, DATA-DRIVEN PLAN
Step 1: Check labs
Start with 25(OH)D. If you have kidney disease, abnormal calcium, or a complex endocrine situation, ask your clinician whether additional testing fits your case.
Step 2: Build a steady routine
Pair outdoor daytime light exposure with a consistent sleep schedule. Outdoor walks help circadian rhythm and stress physiology. If winter blocks UVB, use a UVB vitamin D lamp on a schedule that matches the user guide.
Step 3: Re-test
Re-test 25(OH)D after a consistent routine. Let data drive changes.
Step 4: If brain fog persists, widen the lens
Vitamin D often plays a role, yet brain fog rarely comes from one factor. Sleep, cortisol rhythm, nutrient status, and post-viral inflammation often stack together.
These posts help you build the full map: Brain fog triggers: https://mindbodyneurology.com/top-10-brain-fog-triggers/ Post-viral recovery: https://mindbodyneurology.com/post-covid-brain-fog-recovery-integrative-neurology/ Peptides and brain fog: https://mindbodyneurology.com/peptides-and-brain-fog-integrative-neurology/Brain fog article hub: https://mindbodyneurology.com/category/brain-fog/
WHY WE RECOMMEND A LAMP INSTEAD OF SUPPLEMENTS
Many people want a non-pill option. A UVB lamp fits that goal. It aligns with physiology. It supports 25(OH)D supply, which supports normal active vitamin D signaling.
If you want a measured winter strategy, review the Sperti Vitamin D Sunlamp here: https://www.sperti.com/ Use it exactly as directed. Track 25(OH)D with lab testing. Treat your plan like a clinical experiment with real data.
If you want help interpreting labs and linking vitamin D with sleep, stress physiology, and brain performance, book your consultation with Mind Body Neurology here:
REFERENCES
NIH Office of Dietary Supplements, Vitamin D fact sheet (25(OH)D as main status marker, tissue conversion, roles)AAFP Choosing Wisely (do not routinely measure 1,25(OH)2D for deficiency screening)PubMed Central review (metabolism sequence, season and glass reduce synthesis)Sperti product page (timer, shutoff, UVB bulbs)
Frequently Asked Questions
Which vitamin D lab test reflects vitamin D status best?
In most cases, 25-hydroxyvitamin D (25(OH)D) reflects vitamin D supply over time and works as the main status marker.
Does sunlight through a window raise vitamin D?
No. Skin vitamin D production needs UVB, and standard window glass blocks UVB.
Why do I sometimes measure both 25(OH)D and 1,25(OH)2D?
In select cases, checking both helps when symptoms and lab patterns do not match the typical picture. Interpretation depends on calcium, kidney function, and clinical context.
Why can 25(OH)D be low while 1,25(OH)2D is high?
This pattern can occur when conversion into the active hormone increases. Common drivers include parathyroid hormone effects and, less commonly, immune-driven conversion outside the kidney in granulomatous inflammation. Context and calcium handling guide next steps.

